Clinical trial

Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal

NCT06176794

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2024-11-15

PhasePHASE2

Study timeline

Study start (actual)2024-11-15Date precision: day

Registry last updated2026-04-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

Immediate release torsemide 20mg tabletDRUG

Extended release torsemide 24mg tabletDRUG

Sponsors & collaborators

Sarfez Pharmaceuticals, Inc.lead sponsor

Mapped research locations

GainesvilleFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06176794 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.